Copper, an essential nutrient, has been implicated in vascular remodeling and atherosclerosis with unknown mechanism. Bioavailability of intracellular copper is regulated not only by the copper importer CTR1 (copper transporter 1) but also by the copper exporter ATP7A (Menkes ATPase), whose function is achieved through copper-dependent translocation from trans-Golgi network (TGN). Platelet-derived growth factor (PDGF) promotes vascular smooth muscle cell (VSMC) migration, a key component of neointimal formation. Res. 2010;107:787-799.) 
C opper, an essential micronutrient, plays an important role in physiological repair processes including wound healing and angiogenesis, as well as various pathophysiologies including tumor growth, neurodegenerative disease, and atherosclerosis. [1] [2] [3] [4] [5] [6] [7] Copper levels are significantly increased in cancer and atherosclerotic lesions. 8, 9 Implanting a copper cuff promotes neointima thickening in response to vascular injury, 10 whereas copper chelators prevent this response 11 and tumor growth. 3 Underlying molecular mechanisms remain unclear. Platelet-derived growth factor (PDGF) is a key growth factor to promote neointimal formation and vascular remodeling in vivo primarily through the PDGF receptor-␤ (PDGFR) expressed in vascular smooth muscle cells (VSMCs). 12 VSMC migration is a critical event for the development of atherosclerosis and restenosis after vascular injury. 12 PDGF-induced cell migration is regulated by actin cytoskeleton, Rac1 activation and translocation to the leading edge. 12, 13 However, a role for copper in PDGF-induced VSMC migration has not been demonstrated.
Because excess copper is toxic, copper homeostasis is tightly controlled by regulation of copper uptake, transport and excretion. 1, 2 Indeed, under physiological conditions, the level of intracellular free copper is extraordinarily restricted. 14 Copper uptake is mainly mediated by the copper transporter (CTR)1 copper importer, which is involved in embryonic development. 1, 15 Once copper enters the cell via CTR1, it can be delivered into various distinct cellular compartments via ATP7A copper transporting ATPase through the Atox1 copper chaperone. 16, 17 ATP7A is ubiquitously expressed and transports copper to the extracellular space or to the selected copper enzymes, which are either secreted from cells, or reside within vesicular compartments. 16, 17 When intracellular copper increases, ATP7A translocates from trans-Golgi network (TGN) to the plasma membrane or to cytoplasmic vesicles, 16, 17 thereby maintaining intracellular copper homeostasis and avoiding copper toxicity. This process requires both copper binding to cytoplasmic regions of ATP7A as well as its catalytic turnover. 18, 19 The biological significance of ATP7A in vivo is underscored by Menkes disease, a disorder caused by ATP7A mutations resulting in a marked decrease in copper levels in most tissues except for the kidney and small intestine. Menkes patients show multiple abnormalities secondary to either loss of activity of some secretory copper enzymes or impairment of neuronal activation and other unknown function, leading to death in infancy. 2, 20 In vascular tissue, ATP7A is involved in delivering copper to secretory copper enzymes, such as superoxide dismutase (SOD)3 and proenzyme of lysyl oxidase (Pro-LOX). 17,20 -22 After secretion, Pro-LOX is processed and activated by proteolysis to a mature active 32-kDa enzyme (LOX) and an 18-kDa propeptide (LOX-PP), both of which are expressed in vascular tissue. 22, 23 LOX is known to be critical for vascular extracellular matrix maturation by regulating the cross-linking of collagens or elastin. Of note, LOX is stimulatory but LOX-PP is inhibitory for cell migration. [23] [24] [25] No information is available regarding a role of ATP7A in PDGF-mediated vascular migration and remodeling.
Here, we demonstrate the novel role of ATP7A in PDGFinduced VSMC migration. PDGF stimulation promotes ATP7A translocation from the TGN to lipid rafts which localize at the leading edge in migrating VSMC, thereby promoting lamellipodia formation through recruiting Rac1, in a CTR1-dependent manner. This is associated with a decrease in cellular copper and secretory copper enzyme precursor prolysyl oxidase in caveolae/lipid rafts, which may contribute to activation of LOX. In vivo, ATP7A expression is markedly increased and copper accumulation is observed at neointimal VSMC in wire injury model. These findings provide insight into ATP7A as potential therapeutic targets for vascular remodeling and development of atherosclerosis.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Detergent-Free Purification of Caveolin-Rich Membrane Fractions
Caveolae/lipid raft fractions were separated by the sodium carbonate-based detergent-free method.
Copper Measurements
Copper contents were analyzed by inductively coupled plasma mass spectrometry (ICP-MS) using a PlasmaQuad3, as reported previously. 26 
Vascular Injury
Animal protocols were approved by the Animal Care and Use Committee of the University of Illinois at Chicago and University of Minnesota. Wire-induced injury of the carotid artery in apolipoprotein (Apo)E-deficient atherosclerotic mice was performed, as reported previously. 27
Synchrotron X-Ray Fluorescence Microscopy
Sections (5-m thick) of formalin-fixed, paraffin-embedded, wireinjured femoral artery were used. For x-ray imaging, the sections (5-m thick) of formalin-fixed, paraffin-embedded, wire-injured femoral artery were prepared on silicon nitride windows (Silson), as reported previously. 28
Results

Expression of the ATP7A Copper Transporter and the CTR1 Copper Importer in VSMCs
RT-PCR analysis of rat, mouse, and human aortic smooth muscle cells (RASMs, HASMs, and MASMs) detected both ATP7A and CTR1 expression ( Figure 1A ). Western analysis with anti-ATP7A antibody showed expression of ATP7A with a 178-kDa protein in whole cell lysates of RASMs, HASMs, and MASMs ( Figure 1B ). 16, 17 By contrast, CTR1 protein was not detected in whole cell lysates, but in caveolae/lipid rafts fraction, by specific anti-CTR1 antibody, as shown later ( Figure 5A 
ATP7A Is Involved in PDGF-Induced VSMC Migration in a Copper-Dependent Manner
We next examined the role of ATP7A in VSMC migration. Modified Boyden chamber assays demonstrated that knockdown of endogenous ATP7A expression with small interfering (si)RNA significantly inhibited PDGF-stimulated migration in VSMCs ( Figure 1C and Online Figure I ). Because the Figure 1C ) as well as copper chelators tetrathiomolybdate (TTM) (cell-permeable) and bathocuproine disulfonate (BCS) (cell-impermeable) ( Figure 1D ), suggesting that this response is copper-dependent. Wound scratch assay of confluent monolayer of VSMCs in the presence of PDGF also showed that ATP7A siRNA as well as CTR1 siRNA or BCS significantly inhibited directional cell migration in response to wound injury ( Figure 1E ). In contrast, transfection of ATP7A siRNA did not have significant effect on PDGFinduced VSMC proliferation (Online Figure II) . These results suggest that ATP7A is involved in PDGF-stimulated VSMCs migration in a copper-dependent manner.
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PDGF Stimulation Promotes ATP7A Translocation to the Leading Edge in a Copper-Dependent Manner
To gain insight into the mechanism by which ATP7A mediates VSMC migration in response to PDGF, we examined the subcellular localization of ATP7A after wound scratch in the presence of PDGF. In confluent monolayers of VSMC before wounding or in migrating VSMCs away from the scratched area, ATP7A was found predominantly in perinuclear regions ( Figure 2A ). In contrast, ATP7A accumulated and colocalized with F-actin at the leading edge in actively migrating VSMCs, but did not colocalize with actin stress fibers in the cell body ( Figure 2A ). We confirmed the specificity of the ATP7A staining by ATP7A siRNA, as shown later ( Figure 3D ). Furthermore, nonimmune IgG (control) showed no staining (data not shown). Pretreatment of VSMCs with copper chelators BCS or TTM as well as CTR1 siRNA markedly inhibited wound-induced transloca- tion of ATP7A toward the leading edge ( Figure 2B ). Similarly, in untreated VSMC, ATP7A was found predominantly in perinuclear regions, and colocalized with syntaxin 6, a TGN marker (Online Figure III, B ). PDGF stimulation rapidly promoted ATP7A translocation from the Golgi to the plasma membrane leading edge with peak at 5 minutes, which gradually returned to the perinuclear region within 30 minutes ( Figure 2C ; Online Figure III , A). This effect was observed in VSMCs from other species, such as MASMs, suggesting that function of ATP7A is similar in VSMC across the different species (Online Figure III, C). Furthermore, this response was inhibited by copper chelators as well as knockdown of CTR1 ( Figure 2D ). Of note, the location of syntaxin 6 was not altered by PDGF in VSMCs (Online Figure III, B ), suggesting that PDGF-induced ATP7A translocation was not attributable to the general effect on Golgi structure. Taken together, these findings suggest that PDGF stimulation promotes ATP7A translocation to the leading edge, in a copperdependent manner, thereby stimulating VSMC migration.
ATP7A Is Involved in PDGF-Stimulated Lamellipodia Formation and Rac1 Translocation in a CTR1-Dependent Manner in VSMCs
To assess further the mechanism by which ATP7A is involved in VSMC migration, we examined whether ATP7A is involved in actin reorganization. Knockdown of ATP7A by siRNA significantly impaired wound scratch-( Figure 3A ) and PDGF-( Figure 3B ) stimulated lamellipodia formation at the leading edge in VSMCs as visualized by phalloidin staining. These effects were also prevented by siRNA knockdown of the CTR1. Because Rac1 plays a role in lamellipodia formation and cell migration, 31 we next examined the role of ATP7A in Rac1 activation and translocation in PDGFstimulated VSMCs. PDGF stimulation increased active, GTP-bound form of Rac1 within 1 minute, which was not affected by either ATP7A or CTR1 siRNA (Online Figure  IV) . Immunofluorescence analysis showed that PDGF stimulation promoted translocation of Rac1 to the leading edge where it colocalized with ATP7A ( Figure 3C ). Coimmuno- precipitation analysis showed that ATP7A associated with Rac1 in the basal state, which was further enhanced after PDGF stimulation (Online Figure IV, C), suggesting that ATP7A recruits Rac1 to the lipid rafts via binding to Rac1 in response to PDGF directly or indirectly. Furthermore, Rac1 trafficking to the leading edge was inhibited by either ATP7A or CTR1 siRNA ( Figure 3D ). Thus, the copper transporter ATP7A is involved in PDGF-stimulated translocation of Rac1 to the leading edge, but not Rac1 activation, in a CTR1-dependent manner, which may contribute to lamellipodia formation and VSMC migration.
ATP7A Colocalizes With PDGFR at the Leading Edge in a CTR1-Dependent Manner in PDGF-Stimulated VSMCs
Because we found that ATP7A is a downstream mediator for PDGFR signaling linked to VSMC migration, we next examined the relationship between ATP7A and PDGFR in PDGF-stimulated VSMCs. Immunofluorescence analysis showed that ATP7A colocalized with PDGFR at the leading edge after PDGF stimulation ( Figure 4A ). Of note, both CTR1 and ATP7A siRNAs inhibited PDGF-induced ATP7A movement to the leading edge without affecting PDGFR localization ( Figure 4B ). Coimmunoprecipitation analysis further confirmed that PDGF stimulation promoted PDGFR association with ATP7A, which was somewhat inhibited by CTR1 siRNA ( Figure 4C ). Under this condition, PDGFinduced PDGFR autophosphorylation was not affected by CTR1 siRNA ( Figure 4C ). Taken together, these results suggest that PDGF stimulation induces colocalization and association of ATP7A with PDGFR at the leading edge in a CTR1-dependent manner, and that CTR1-ATP7A pathway is downstream of PDGFR activation.
PDGF Promotes ATP7A Recruitment to the Caveolae/Lipid Rafts, Where PDGFR, Rac1, and CTR1 Are Localized, in a CTR1-Dependent Manner
To gain further insight into the subcellular compartments in which ATP7A is localized, we performed detergent-free sucrose gradient fractionation in VSMCs, as previously described. 32 Western analysis of sequential fractions from the gradient showed that ATP7A was found in both caveolinenriched lipid rafts fractions and noncaveolae/lipid rafts fractions which mainly contain paxillin ( Figure 5A ). 33 By contrast, the CTR1 copper importer was predominantly found in caveolae/lipid rafts. The specificity of the CTR1 antibody, which detects glycosylated CTR1, 34 was verified by CTR1deficient mouse embryonic fibroblast cells 30 and VSMCs Figure 5B shows that PDGF stimulation for 5 minutes promoted recruitment of ATP7A, CTR1 and Rac1 to the caveolae/lipid rafts fractions without affecting PDGFR localization, which was associated with an increase in PDGFR phosphorylation in these fractions. Significantly, CTR1 siRNA prevented PDGF-induced translocation of ATP7A and Rac1 to the caveolae/lipid rafts without affecting PDGFR phosphorylation ( Figure 5B ). These suggest that PDGF-induced PDGFR autophosphorylation occurs in caveolae/lipid rafts, which in turn promotes recruitment of ATP7A and Rac1 to these specialized microdomains where PDGFR is localized, in a CTR1-dependent manner.
ATP7A Is Translocated to the Lipid Rafts Localized at the Leading Edge in PDGF-Stimulated VSMCs
Lipid rafts have been shown to be localized at the leading edge during cell migration. 35 We thus examined the spatial relationships among ATP7A, lipid rafts and leading edge after PDGF stimulation using immunofluorescence analysis. As shown in Figure 5C and Online Figure VI (B) , ATP7A colocalized with cholera toxin subunit B (CTxB), a lipid raft marker, 35 at the leading edge in PDGF-and wound scratchstimulated VSMCs. Furthermore, CTxB accumulated and colocalized with F-actin at the leading edge in actively migrating VSMCs (Online Figure VI , A and C). Disruption of lipid rafts by cholesterol binding reagent, methyl-␤cyclodextrin, completely abrogated the ATP7A localization at the leading edge and CTxB staining ( Figure 5D ) as well as lamellipodia formation (Online Figure VI, A) . These results suggest that PDGF stimulates translocation of ATP7A to the lipid rafts localized at the leading edge, thereby promoting lamellipodia formation.
PDGF Stimulation Reduces Copper Content in Caveolae/Lipid Raft Fractions in VSMCs
Because ATP7A is involved in exporting copper to the extracellular space, we next examined the effects of PDGF on copper levels in VSMCs. At first, we performed 64 Cu Growth-arrested confluent monolayer of RASMs was stimulated with 50 ng/mL PDGF for indicated times (min). Lysates were immunoprecipitate (IP) with anti-PDGFR antibody, followed by immunoblot (IB) with ATP7A, phospho-PDGFR, and PDGFR antibody.
efflux and 64 Cu uptake experiments in cultured VSMCs and found that PDGF stimulation had no effects on either response (Online Figure VII) . Similarly, ICP-MS analysis of total cell lysates of VSMCs also showed that copper contents were not changed after PDGF stimulation ( Figure  6A ). Because ATP7A is recruited to the caveolae/lipid rafts in response to PDGF, we next measured the copper content in the lipid rafts and nonlipid raft fractions. Intriguingly, we found that the caveolae/lipid rafts fraction contains much higher amounts of copper than nonlipid raft fractions in the basal state ( Figure 6B ). Moreover, PDGF stimulation significantly reduced copper content in caveolae/lipid rafts in an ATP7A-dependent manner ( Figure 6C and Online Figure VIII) . These results suggest that PDGFinduced recruitment of ATP7A to the lipid rafts may contribute to copper export to the extracellular space in these specialized microdomains. This was not detected by global measurements of 64 Cu efflux and 64 Cu uptake in whole cells. The plasma membrane localization of ATP7A and CTR1 in PDGF-stimulated VSMCs was confirmed by using cell surface biotinylation assays (Online Figure IX) . We next examined whether PDGF-induced decrease in copper content in caveolae/lipid rafts may reflect the secre-tion of copper-binding proteins, such as Pro-LOX which obtain copper from ATP7A. We found that pro-LOX was localized in caveolae/lipid rafts in the basal state, and PDGF stimulation promoted the reduction of pro-LOX level in an ATP7A dependent manner in these fractions ( Figure 6D and 6E; Online Figure X ). After secretion, Pro-LOX is processed to a mature active nonglycosylated LOX and a glycosylated propeptide LOX-PP. 22, 23 Of note, LOX and LOX-PP were not found in caveolae/lipid rafts in the basal state or after PDGF treatment ( Figure 6D and 6E) . Taken together, these findings suggest that PDGF-stimulated ATP7A recruitment into the caveolae/lipid rafts may be required for the secretion of copper-dependent enzymes such as pro-LOX localized in these specific compartments.
It has been reported that ATP7A is involved in LOX activity 17, 36 and that LOX activity is involved in PDGFinduced VSMC migration 24 in addition to its effect on extracellular matrix remodeling. We thus examined whether LOX activity is involved in copper transporter ATP7Adependent PDGF-induced VSMC migration. ATP7AsiRNA significantly inhibited LOX activity in VSMCs treated with PDGF (Online Figure XII, A) . Furthermore, treatment of a specific chemical LOX activity inhibitor, ␤aminopropion- Figure XII, B) , which is consistent with the report by Lucero et al. 24 These findings suggest that LOX activity is involved in PDGF-induced, ATP7A-dependent VSMC migration.
itrile (BAPN), significantly inhibits PDGF-induced VSMC migration (Online
ATP7A Is Upregulated in Neointimal Formation in Response to Vascular Injury In Vivo
To determine the functional significance of ATP7A in VSMC migration in vivo, we examined the role of ATP7A in neointimal formation using a mouse wire injury model.
Figure 6. PDGF stimulation reduces copper content and Pro-LOX in lipid rafts fractions in VSMCs. A through C, Copper contents were measured by ICP-MS in whole cells (A) or caveolae/lipid rafts or noncaveolae/lipid rafts (B and C)
in RASMs with or without PDGF stimulation for 5 minutes. Equal amounts of proteins in caveolae/lipid rafts (fractions 4 to 5) or noncaveolae/lipid rafts (fractions 9 to 13) were obtained by sucrose gradient fractionation as described for Figure 5 . *PϽ0.05 vs nonlipid rafts or unstimulated cells (meansϮSD, nϭ3). D, Identification of Pro-LOX, but not LOX, in caveolae/lipid rafts in VSMCs. RASMs were fractionated by sucrose gradient centrifugation, followed by immunoblotted with anti-LOX-PP (which detects both Pro-Lox and LOX-PP), anti-LOX, or anticaveolin-1 antibodies. E, Effect of PDGF treatment on Pro-LOX level in caveolae/lipid rafts fractions in VSMCs. Equal amounts of proteins in caveolae/lipid rafts (fractions 4 to 5) were immunoblotted with anti-LOX-PP, -LOX, or -caveolin-1 antibodies in RASMs with or without 50 ng/mL PDGF for 5 minutes.
Immunohistochemical analysis showed that ATP7A protein expression was robustly increased in neointimal VSMC and endothelial cells lining the lumen in the injured vessel of ApoE-deficient atherosclerotic mice ( Figure 7A) . Immunofluorescence analysis demonstrated that ATP7A was colocalized with ␣-smooth muscle actin, a VSMC marker, in the neointima formed in response to injury ( Figure 7B ). We next examined if induction of ATP7A precedes VSMC migration after injury to address the cause-effect of ATP7A in VSMC migration in vivo. As shown in Online Figure XI , we observed increase in ATP7A expression at 3 days after wire injury in the vessels of ApoE-deficient atherosclerotic mice, whereas there was no VSMC migration and neointima formation at this time point as reported by Linder et al. 37 Thus, these findings suggest that ATP7A expression is increased before the onset of VSMC migration following vascular injury and this upregulation is also observed in neointimal VSMCs. Finally, we examined spatial distribution of copper in neointima using synchrotron-based x-ray fluorescence microscopy (SXFM). 28 As shown in Figure 7C , copper accumulation was observed at neointimal lesions in wire injury model. These results suggest that ATP7A may be involved in neointima formation in response to vascular injury in vivo.
Discussion
A role for copper in tissue repair, neointima thickening and atherosclerosis has been suggested; however, the underlying detailed mechanisms remain unknown. 3-7,9 -11 Here we provide novel evidence that the ATP7A copper transporter is involved in PDGF-stimulated VSMC migration, which is critical for neointimal formation and vascular remodeling (Figure 8 ). We found that stimulation with PDGF promotes ATP7A translocation from TGN to the leading edge. This PDGF-induced ATP7A movement toward the site of actin remodeling is inhibited by cell permeable and impermeable copper chelators as well as depletion of the CTR1 copper importer. It has been shown that relocalization of ATP7A from the Golgi is triggered by increased cytoplasmic copper as well as by estrogen, insulin, NMDA (N-methyl-Daspartate) activation, hypoxia, and cytokines. 2, 16, 38, 39 However, our data are the first demonstration that the ATP7A copper transporter translocates to the leading edge during growth factor-stimulated cell migration. It has been reported that ATP7A trafficking is in part dependent on its catalytic activity, which requires copper binding to conserved cysteines within its N-terminal region. [17] [18] [19] Extracellular copper influx is mainly mediated through CTR1, the copper importer, which is also the major source of "bioavailable" copper for ATP7A via the Atox1 copper chaperone. 29, 30 Indeed, Atox1 siRNA prevented PDGF induced ATP7A translocation to the leading edge, suggesting that Atox1 is involved in PDGF-induced translocation of ATP7A (data not shown). Thus, our findings are consistent with the possibility that ATP7A obtains copper via Atox1 by stimulating extracellular copper uptake through CTR1 in response to PDGF, thereby promoting ATP7A trafficking from the Golgi to the leading edge in VSMCs. However, we failed to detect a PDGF-induced increase in 64 Cu uptake in whole cell labeling of VSMCs with 64 Cu in this study. This may be attributable to the possibility that CTR1-mediated copper uptake occurs in the specific plasma membrane compartment, as discussed below. It is not known how ATP7A is translocated to the leading edge after PDGF stimulation in a copper-dependent manner. Phosphorylation of ATP7A has been shown to be involved in copper-induced relocalization of this protein. 40 Thus, it is possible that PDGF stimulation may induce phosphorylation of ATP7A, which may contribute to its translocation to the leading edge. Taken together, our findings provide a novel linkage between copper homeostasis and PDGF-induced VSMC migration.
Migrating cells form protrusions, such as lamellipodia, by reorganizing of the actin cytoskeleton at the leading edge, which plays an important role in cell migration. The small G protein family Rac1 plays a key role in lamellipodia formation 31 and PDGF-stimulated cell migration. 13 In the present study, we demonstrate that ATP7A is involved in PDGF-induced lamellipodia formation and Rac1 translocation to the leading edge without affecting Rac1 activity, in a copper-and CTR1-dependent manner. Coimmunoprecipitation analysis showed that ATP7A as-sociated with Rac1 in the basal state, which was further enhanced after PDGF stimulation (Online Figure IV, C) , suggesting that ATP7A recruits Rac1 to the lipid rafts via binding to Rac1 in response to PDGF directly or indirectly. In line with our data, previous reports show that trafficking of ATP7A from the TGN to the cell surface is associated with actin networks and involves Rac1, which is distinct from the major constitutive secretory pathway. 16, 41 Of note, PDGF stimulation also promotes colocalization and association of ATP7A with PDGFR at the leading edge. However, CTR1 siRNA prevents ATP7A translocation to the leading edge without affecting PDGFR localization and its autophosphorylation. These results suggest that CTR1-ATP7A-Rac1 pathway is downstream of PDGFR activation involved in lamellipodia formation and VSMC migration.
Caveolae and lipid rafts are specialized membrane microdomains that are highly enriched in cholesterol and sphingolipids and function as platforms for assembly of signaling molecules including G proteins and receptors involved in various functions. 35 In chemoattractant-stimulated cancer cells, lipid rafts are accumulated at the leading edge. 35 Using sucrose gradient fractionation, the present study shows that PDGF stimulation promotes recruitment of ATP7A and Rac1 to the caveolae/lipid rafts where CTR1 and PDGFR are localized, in a CTR1-dependent manner. By contrast, CTR1 siRNA has no effect on PDGF-induced PDGFR tyrosine phosphorylation as well as localization of caveolin-1 and PDGFR in caveolae/lipid rafts fractions, suggesting that the structure of caveolae/lipid rafts is intact in CTR1 depleted VSMCs. Immunofluorescence analysis also reveals that the marker for lipid rafts, CTxB, 35 colocalizes with ATP7A at the leading edge of migrating VSMCs. We confirmed the plasma membrane localization of ATP7A and CTR1 in PDGFstimulated VSMCs using cell surface biotinylation assays. PDGF-induced Rac1 translocation to the lipid rafts has been reported in Rat-1B cells 13 ; however, our data provides the first evidence that copper transporters CTR1 and ATP7A are localized in these specialized plasma membrane microdo- PDGF promotes ATP7A translocation from the TGN to the lipid rafts, which localize at the leading edge, thereby stimulating lamellipodia formation via recruiting Rac1, which in turn promotes directional VSMC migration involved in neointimal formation. This is associated with a decrease in cellular copper level and secretory copper enzyme prolysyl oxidase (Pro-LOX) at the lipid rafts, which is extracellularly processed and activated by proteolysis to a mature lysyl oxidase (LOX) and a propeptide (LOX-PP), which may promote extracellular matrix (ECM) remodeling and VSMC migration. Secreted copper may also contribute to PDGF-induced cell migration.
mains. Functional significance of copper-dependent ATP7A trafficking into lipid rafts is demonstrated by showing that disruption of lipid rafts by the cholesterol-binding reagent, methyl-␤-cyclodextrin, completely inhibits PDGF-induced ATP7A translocation to the leading edge as well as lamellipodia formation. Moreover, PDGF stimulation rapidly decreases the copper content of caveolae/lipid rafts in an ATP7A-dependent manner, as measured by ICP-MS. This PDGF effect is associated with recruitment of ATP7A to lipid rafts where CTR1 is predominantly found. The rapid kinetics of ATP7A is reminiscent of copper-induced ATP7A recruitment into a fast-recycling pool located in close proximity with the plasma membrane. 2, 16, 17, 42 Hung YH et al have reported that the copper content of lipid rafts is paradoxically decreased, when cytoplasmic copper is increased. 43 Thus, it is conceivable that PDGF may stimulate copper uptake via CTR1 to provide copper to ATP7A, which in turn promotes ATP7A translocation from the Golgi to the caveolae/lipid rafts to export copper to extracellular space in the specific compartments. Interestingly, we could not detect any changes in copper levels in response to PDGF in total cell lysates. This may support the suggestion that global measurements of 64 Cu efflux and 64 Cu uptake in whole cells would fail to detect compartmentalized changes of copper distribution observed in the present study.
The physiological consequence of copper export via ATP7A is not merely the elimination of excess cellular copper, but to supply adequate copper to the developing fetus as gestation progresses, 16 or to provide copper as part of a neuronal protective mechanism. 2 Using SXFM, Finney et al reported that copper is transported from intracellular compartments to the tips of endothelia during capillary growth, which is required for capillary tube formation. 28 In the present study, we demonstrate that the copperdependent Pro-LOX, which is secreted and activated in the extracellular space, 22 is localized at caveolae/lipid rafts in the basal state. PDGF stimulation significantly reduces Pro-LOX levels in caveolae/lipid rafts fractions in an ATP7A-dependent manner. This may reflect the secretion of pro-LOX after obtaining copper from the recruited ATP7A in these specialized compartments. Importantly, recent evidence suggests that LOX and LOX-PP, both of which are produced from Pro-LOX through proteolysis in the extracellular space, have opposite effects on cell migration. [23] [24] [25] Furthermore, and consistent with our results, ATP7A has been shown to deliver copper to some secretory copper enzymes in the post-Golgi vesicles rather than in the TGN, where copper loading normally takes place. 38, 44 Taken together, these findings suggest that copper-dependent ATP7A trafficking to lipid rafts in response to PDGF may not simply reflect export copper to the extracellular space, but also facilitate copper-loading to pro-LOX in post-Golgi compartments such as lipid rafts, thereby promoting VSMC migration. To support this, we found that ATP7A siRNA significantly inhibited LOX activity in VSMCs treated with PDGF and that the chemical LOX activity inhibitor ␤-aminopropionitrile significantly blocked PDGF-induced VSMC migration.
A functional role of the copper transporter ATP7A in VSMC migration in vivo is underscored by upregulation of ATP7A expression and copper accumulation (shown by SXFM) in intimal a-smooth muscle actin positive cells. Of note, ATP7A expression is increased before the onset of VSMC migration after vascular injury and this upregulation was also observed in neointimal VSMCs at later time. These findings suggest that ATP7A may play a role in VSMC migration in vivo. Previous reports indicate that copper plays an important role in various cardiovascular diseases and cancer. High serum copper levels are associated with an increased future risk of coronary heart disease. 4, 5, 7 Atherosclerotic lesions have higher copper levels than normal tissues. 9 Neointimal thickening after vascular injury is inhibited by copper chelation 11 and increased by copper cuffs and stents. 10 Copper deficiency therapies prevent tumor progression in clinical trials. 3 Interestingly, we found that ATP7A is involved in PDGFstimulated decrease in copper level and Pro-LOX in caveolae/lipid rafts as well as PDGF-stimulated increase in LOX activity in VSMCs. Furthermore, we showed that inhibition of LOX activity blocks PDGF-induced VSMC migration as reported previously. 24 Given that LOX activity is also essential for vascular extracellular matrix maturation, these results suggest that ATP7A copper transporter may promote extracellular matrix deposition, as well as neointimal formation after vascular injury via regulation of LOX activity. 45 In addition, one of the major copper-and ATP7A-dependent enzymes regulating ROS metabolism is SOD3, but not either SOD1 or SOD2. 21 We thus investigated the contribution of SOD3 but found that SOD3 siRNA had no effect of PDGF-induced directional VSMC migration (Online Figure XII, C) . X-ray fluorescence microscopy scans do not clearly show codistribution of copper levels with ATP7A. This may be attributable to the possibility that copper secreted by ATP7A is more widely distributed because of the diffusible nature as ions, and that other copper binding proteins may be involved in neointima formation. Taken together with in vitro data, our findings indicate that upregulation of ATP7A and copper accumulation in neointimal VSMCs may contribute to neointimal formation and vascular remodeling in vivo at least in part by regulating VSMC migration and LOX activity. Because our vascular injury data implicates but does not conclude that ATP7A may play a role in VSMC migration in vivo, further investigation will be required using ATP7A mutant mice 46 in future study.
In conclusion, the present study uncovers a novel function of ATP7A as a regulator for PDGF-induced VSMC migration via recruiting Rac1 to lipid rafts at the leading edge in a copper dependent manner, as well as controlling LOX activity, which may contribute to vascular remodeling (Figure 8 ). They also indicate an important new role for lipid rafts in organizing the protein components involved in copper homeostasis and signaling. Our findings also provide insight into ATP7A as a potential therapeutic target for various pathophysiologies, such as atherosclerosis, postangioplasty restenosis, diabetes, and cancer, which are associated with dysregulation of cell migration.
What New Information Does This Article Contribute?
• Copper transporter ATP7A plays an important role in PDGF-induced VSMC migration in a copper-dependent manner. • PDGF stimulation promotes ATP7A translocation from the trans-Golgi network (TGN) to the lipid raft microdomains which localize at the leading edge, thereby promoting lamellipodia formation through recruiting Rac1 as well as increasing lysyl oxidase (LOX) activity. • In vivo, ATP7A expression is upregulated and copper accumulation is observed in neointimal VSMC in response to vascular injury.
Copper, an essential micronutrient, has been implicated in vascular remodeling in response to injury by unknown mechanisms. Because excess copper is toxic, bioavailability of copper is tightly controlled not only by the copper importer CTR1, but also by the copper exporter ATP7A. Function of ATP7A is achieved through copper-dependent translocation from TGN. We investigated a role of ATP7A in PDGF-induced VSMC migration, a key component of neointimal formation after vascular injury. Here we show that depletion of ATP7A inhibits PDGF-induced VSMC migration in a copper/CTR1 dependent manner. Mechanistically, PDGF stimulation promotes ATP7A translocation from TGN to the lipid raft microdomains which localize at the leading edge in migrating VSMCs, thereby promoting lamellipodia formation through recruiting Rac1, as well as regulating LOX activity. In vivo, ATP7A is markedly increased in neointimal VSMC in wire injury model, in which copper accumulation is observed. Our findings uncover an unexpected role of ATP7A as a regulator of vascular migration in response to injury and provide insight into copper transporters as potential therapeutic targets for vascular remodeling and atherosclerosis. Furthermore, our studies will suggest a novel linkage between copper homeostasis and vascular migration.
